These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1119 related items for PubMed ID: 9451816

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide.
    de Kievit TR, Lam JS.
    J Bacteriol; 1994 Dec; 176(23):7129-39. PubMed ID: 7525538
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous Pseudomonas aeruginosa Strains Based on Expression Profiling of Outer Membrane Proteins During Infection.
    Liu C, Pan X, Xia B, Chen F, Jin Y, Bai F, Priebe G, Cheng Z, Jin S, Wu W.
    Front Immunol; 2018 Dec; 9():1737. PubMed ID: 30093906
    [Abstract] [Full Text] [Related]

  • 6. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G.
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies as probes to examine serotype-specific and cross-reactive epitopes of lipopolysaccharides from serotypes O2, O5, and O16 of Pseudomonas aeruginosa.
    Lam JS, Handelsman MY, Chivers TR, MacDonald LA.
    J Bacteriol; 1992 Apr; 174(7):2178-84. PubMed ID: 1372599
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunological studies of an artificial antigen with specificity of a common polysaccharide antigen of Pseudomonas aeruginosa.
    Makarenko TA, Kocharova NA, Edvabnaya LS, Tsvetkov YE, Kholodkova EV, Knirel YA, Backinowsky LV, Kochetkov NK, Stanislavsky ES.
    FEMS Immunol Med Microbiol; 1993 Oct; 7(3):251-6. PubMed ID: 7506094
    [Abstract] [Full Text] [Related]

  • 14. Novel O-polysaccharide expression, as a lipid A-core-free form, in a lipopolysaccharide-core-defective mutant of Pseudomonas aeruginosa.
    Yokota SI.
    Microbiology (Reading); 1996 Feb; 142 ( Pt 2)():289-297. PubMed ID: 8932702
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Conjugation of alginate to a synthetic peptide containing T- and B-cell epitopes as an induction for protective immunity against Pseudomonas aeruginosa.
    Farjaha A, Owlia P, Siadat SD, Mousavi SF, Shafieeardestani M.
    J Biotechnol; 2014 Dec 20; 192 Pt A():240-7. PubMed ID: 25449544
    [Abstract] [Full Text] [Related]

  • 18. [Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes].
    Kholodkova EV, Fedotova IuM, Stanislavskiĭ ES.
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug 20; (8):47-50. PubMed ID: 2446445
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.
    Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB.
    Infect Immun; 2011 Aug 20; 79(8):3455-64. PubMed ID: 21628521
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.